William Merritt, M.D.

Research Resident

Dr. Merritt’s research interests are in investigating and innovating in the realm of translating experimental therapies for clinical use. He is currently part of the development project to investigate gene editing strategies for non-small cell lung carcinoma, where he aids the Division of Surgical Oncology with the development and implementation of clinical research projects. Dr. Merritt provides a unique clinical perspective to augment the investigational research performed at the Gene Editing Institute, aiding in the transition from bench to bedside.